Naproxen Sodium

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

31 Suppliers, 23 USDMF, 7 CEP/COS, 6 EU WC, 35 KDMF, 13 NDC API, 9 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

145 Dossiers, 85 FDA Orange Book, 13 Europe, 19 Canada, 4 South Africa, 24 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 500MG BASE, TABLET;ORAL - 220MG, TABLET, EXTENDED RELEASE;ORAL - EQ 375MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 500MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 750MG BASE, CAPSULE;ORAL - EQ 200MG BASE, TABLET;ORAL - 500MG;EQ 85MG BASE, TABLET;ORAL - 60MG;EQ 10MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 38 Roquette, 33 Kerry, 33 BASF, 20 Microlex e.U, 19 SPI Pharma, 17 Corel Pharma Chem, 13 Seppic, 13 Gangwal Chemicals, 12 Gangwal Healthcare, 12 Sigachi Industries, 12 Nanjing Well Pharmaceutical, 11 Actylis, 11 Boai NKY Pharmaceuticals Ltd, 11 Ideal Cures Pvt Ltd, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Lonza Capsugel, 6 DFE Pharma, 5 Ingredion Pharma Solutions, 4 ACG Worldwide, 4 Kima Chemical, 4 Pharmatrans-Sanaq, 4 Rochem International Inc, 4 DKSH, 4 Prachin Chemical, 4 Ulanqab Kema New Material, 4 Vasa Pharmachem, 3 The Dow Chemical Company, 3 Clariant, 3 Evonik, 2 Nomisma Healthcare, 2 Qualicaps, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Aeon Procare, 2 Seqens, 2 Finar, 2 Pfanstiehl, 2 Jai Radhe Sales, 1 Zhejiang Huakang Pharmaceutical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Alcedo Pharmachem, 1 Vertellus, 1 Nanjing Bold Chemical

EXCIPIENTS BY APPLICATIONS

97 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 46 Direct Compression, 44 Controlled & Modified Release, 44 Disintegrants & Superdisintegrants, 36 Solubilizers, 35 Thickeners and Stabilizers, 30 Granulation, 29 Parenteral, 28 Film Formers & Plasticizers, 26 Taste Masking, 23 Lubricants & Glidants, 22 Topical, 19 Chewable & Orodispersible Aids, 18 Co-Processed Excipients, 9 API Stability Enhancers, 9 Empty Capsules, 8 Rheology Modifiers, 7 Emulsifying Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

46 US Medicaid Prescriptions, 10 Finished Drug Prices

MARKET PLACE

35 APIs, 2 DOSSIERS // FDF

PATENTS

12 US Patents, 2 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 3 EDQM Standards, 1 USP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 44 News

Drug Approvals by the Medicines Control Council in South Africa containing Naproxen Sodium. Original Data : South African Medicines Price Registry

Naproxen Sodium

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

31 Suppliers

23 USDMF

7 CEP/COS

6 EU WC

35 KDMF

13 NDC API

9 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

145 Dossiers

85 FDA Orange Book

13 Europe

19 Canada

4 South Africa

24 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 500MG BASE

TABLET;ORAL - 220MG

TABLET, EXTENDED RELEASE;ORAL - EQ 375MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 500MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 750MG BASE

CAPSULE;ORAL - EQ 200MG BASE

TABLET;ORAL - 500MG;EQ 85MG BASE

TABLET;ORAL - 60MG;EQ 10MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers

38 Roquette

33 Kerry

33 BASF

20 Microlex e.U

19 SPI Pharma

17 Corel Pharma Chem

13 Seppic

13 Gangwal Chemicals

12 Gangwal Healthcare

12 Sigachi Industries

12 Nanjing Well Pharmaceutical

11 Actylis

11 Boai NKY Pharmaceuticals Ltd

11 Ideal Cures Pvt Ltd

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Lonza Capsugel

6 DFE Pharma

5 Ingredion Pharma Solutions

4 ACG Worldwide

4 Kima Chemical

4 Pharmatrans-Sanaq

4 Rochem International Inc

4 DKSH

4 Prachin Chemical

4 Ulanqab Kema New Material

4 Vasa Pharmachem

3 The Dow Chemical Company

3 Clariant

3 Evonik

2 Nomisma Healthcare

2 Qualicaps

2 Shijiazhuang Huaxu Pharmaceutical

2 Aeon Procare

2 Seqens

2 Finar

2 Pfanstiehl

2 Jai Radhe Sales

1 Zhejiang Huakang Pharmaceutical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

TABLET;ORAL - EQ 250MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons